LDLR and obesity due to melanocortin 4 receptor deficiency: Hence, direct antibody inhibition of LDLR-mediated inhibition of the lipolysis may contribute to the anti-obesity effect in vivo, which might be further enhanced [27] by the (for whatever reason) slightly reduced LDL serum concentrations in HFD/B4T-treated mice.